Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes
Journal of Clinical Investigation · 15.07.2026 · 136 (14)
DOI: 10.1172/jci204429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 09.06.2026. Verfasst von Mona Arabzadeh und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems and Computational Biology, and. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Breast Neoplasms, Mutation, Hematopoietic Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health and the National Cancer Institute, H. Lee Moffitt Cancer Center & Research Institute.
Abstract (Originalsprache)
Clonal hematopoiesis (CH) is the age-related expansion of mutated hematopoietic stem cells without hematologic abnormalities. In patients with solid tumors, CH is associated with higher mortality and may evolve to therapy-related myeloid neoplasms; however, the mechanisms by which cancer treatments promote CH dynamics remain largely unknown. Here, we analyzed 392 serial samples from a prospective cohort of patients with breast cancer and show that cytotoxic treatments led to strong therapeutic bottlenecks, resulting in significant reductions in hematopoietic allelic populations and differential clonal selection. Positively selected CH that expanded through dose-dependent therapeutic bottlenecks harbored mutations in TP53 , PPM1D , SRCAP , DNMT3A , and YLPM1 . Patients with positively selected CH during treatment had the shortest progression-free and overall survival compared with patients with unchanging or negatively selected CH across all therapies. These findings, validated in independent breast cancer and pan-cancer cohorts, provide strong evidence for the clinical relevance of monitoring CH during cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Systems and Computational Biology, and.
- Center for Biomedical Informatics, Bioinformatics Department, Rutgers Cancer Institute, Rutgers University, New Brunswick, New Jersey, USA.
- Department of Cancer Epidemiology.
- Department of Biostatistics and Bioinformatics, and.
- Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Department of Internal Medicine, University of South Florida, Tampa, Florida, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health and the National Cancer Institute
- H. Lee Moffitt Cancer Center & Research Institute
- Rutgers Cancer Institute Biomedical Informatics Shared Resource
- New Jersey Commission on Cancer Research
Zitieren
APA
Arabzadeh, M., Tang, Y. H., Colin-Leitzinger, C., Marzban, S., Walgenbach, D., Morganti, S., Mahaganapathy, V., Harper, E., Teng, M., Kresovich, J. K., Washington, I., Parsons, H. A., Garber, J. E., West, J., Ganesan, S., Khiabanian, H., & Gillis, N. (2026). Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes. Journal of Clinical Investigation, 136(14). https://doi.org/10.1172/jci204429
Vancouver
Arabzadeh M, Tang YH, Colin-Leitzinger C, Marzban S, Walgenbach D, Morganti S, et al. Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes. Journal of Clinical Investigation. 2026;136(14). doi:10.1172/jci204429
BibTeX
@article{Arabzadeh2026,
author = {Arabzadeh, Mona and Tang, Yi-Han and Colin-Leitzinger, Christelle and Marzban, Sadegh and Walgenbach, Daniel and Morganti, Stefania and Mahaganapathy, Vaidhyanathan and Harper, Erika and Teng, Mingxiang and Kresovich, Jacob K and Washington, Iman and Parsons, Heather A and Garber, Judy E and West, Jeffrey and Ganesan, Shridar and Khiabanian, Hossein and Gillis, Nancy},
title = {Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {14},
doi = {10.1172/jci204429}
}
EUVIMED